South Korea set for global biosimilars leadership
A Frost & Sullivan report has predicted significant growth in the South Korean biosimilars market between now and 2020.
South Korea is likely to become the global leader in the biosimilars market, according to the latest research from Frost & Sullivan.
By 2020, the country is expected to have emerged at the front of the pack, thanks in large part to its government's recent introduction of a regulatory pathway for manufacturing biologics.
Furthermore, the government provides financial and institutional support to help the market and a number of new products and segments are due to be launched between 2013 and 2016 as a result.
Frost & Sullivan predicts that the biosimilars market will earn revenues of $89.8 million in 2017, up from $62.3 million in 2011.
Poornima Srinivasan, a research analyst at the firm, explained the reasons for South Korea's focus on this type of drug.
She revealed: "The South Korean government considers biosimilars drug development significantly cheaper than new drug development.
"Moreover, biosimilars' time-to-market is half of new drugs', making them attractive investment options."
The market faces a number of challenges, including the large upfront investment required to develop biosimilars and the need to prove they are as clinically effective as original biologics.
However, the large number of patent expiries of original biologics between 2011 and 2019 will fuel the market, Ms Srinivasan added.
Related News
-
News Women in Pharma: Hiring Across the Gender Divide
In our monthly series, we interview women from across the pharmaceutical industry and supply chain to discuss the importance of gender diversity in healthcare, the workplace, and beyond. -
Sponsored Content Ashwagandha and Herbal Medicines: Pharma’s Next Big Opportunity
Herbal medicines and nutraceuticals have seen a surge in interest since the onset of the COVID-19 pandemic. Driven by patient interest in prioritising personalised and integrative medicines, the herbal ingredients industry is now faced with concerns pe... -
News Identifying Alzheimer’s Disease biomarker proteins with whole blood tests
A University of Manchester spin-out pharmaceutical company, PharmaKure, has reported successful study results for the quantification of Alzheimer’s Disease biomarker proteins with a whole blood test. -
News Bill & Melinda Gates Foundation to boost mRNA vaccine initiatives in Africa with USD $40m
To address vaccine inequality and accessibility issues, the Bill & Melinda Gates Foundation aims to deliver USD $40m to various biotech companies and vaccine manufacturers in support of mRNA vaccine development. -
News Updated – Changing abortion pill access according to the US FDA and Supreme Court
After the approval of the medical abortion pill, mifepristone, by the US FDA, states across the USA approach the distribution of the pill differently, some ruling against allowing access to the drug. -
News Revolutionising cancer treatment with mRNA-based therapeutics
Global market for mRNA-based oncology therapeutics expected to reach USD $2 billion by 2029, with promising results for the combination of mRNA candidates with immune checkpoint inhibitors to treat solid tumours. -
News Breaking Barriers: Innovations in Oral Solid Dose Form Bioavailability
The effectiveness of a medication often hinges on its bioavailability – the rate and extent at which the active ingredient is absorbed into the bloodstream. When it comes to oral solid dose forms, such as tablets and capsules, the challenge lies ... -
News Choosing the Right CDMO Partner: A Comprehensive Guide
Finding the right partner for the development and manufacturing of your pharmaceutical or biopharmaceutical products is paramount. This is where Contract Development and Manufacturing Organizations (CDMOs) step in, offering their expertise and infrastr...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance